FDA Says Rules for Copying Amgen Biotechnology Drugs to Arrive `Very Soon’ – Bloomberg
By Dr. Matthew Watson
 WBEZ | FDA Says Rules for Copying Amgen Biotechnology Drugs to Arrive `Very Soon' Bloomberg US regulators plan to unveil rules for reviewing the first copies of biologic medicines “very soon,” according to Food and Drug Administration Commissioner Margaret Hamburg. The health-care overhaul ... Has Obama Set Two More Chips on the Table in the Biotech Poker Game?Seeking Alpha |
Uncategorized
Comments Off on FDA Says Rules for Copying Amgen Biotechnology Drugs to Arrive `Very Soon’ – Bloomberg |
February 20th, 2011
This author published 5452 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research